US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NYLI Merger Arbitrage ETF

36.21

+0.28000.78%

Post-market: 36.210.00000.00%16:10 EST

Volume:44.51K

Turnover:1.61M

Market Cap:253.47M

PE:- -

High:36.21

Open:36.15

Low:36.08

Close:35.93

52wk High:36.73

52wk Low:33.21

Shares:7.00M

Float Shares:7.00M

Volume Ratio:2.26

T/O Rate:0.64%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile

Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026

Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MNA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","market":"US","secType":"STK","nameCN":"NYLI Merger Arbitrage ETF","latestPrice":36.21,"timestamp":1770411600000,"preClose":35.93,"halted":0,"volume":44514,"hourTrading":{"tag":"盘后","latestPrice":36.21,"preClose":36.21,"latestTime":"16:10 EST","volume":11,"amount":398.31,"timestamp":1770412204890,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007792930698580605,"floatShares":7000000,"shares":7000000,"eps":0,"marketStatus":"Market Closed","change":0.28,"latestTime":"02-06 16:00:00 EST","open":36.15,"high":36.21,"low":36.077,"amount":1609418.295836,"amplitude":0.003702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":35.93,"sharesOutstanding":7000000,"nav":36.04705,"aum":251711894.47,"bidAskSpread":0.001251,"preHourTrading":{"tag":"盘前","latestPrice":35.93,"preClose":35.93,"latestTime":"08:00 EST","volume":2,"amount":71.86,"timestamp":1770382824439,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.21,"preClose":36.21,"latestTime":"16:10 EST","volume":11,"amount":398.31,"timestamp":1770412204890,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.2613616885269208,"impliedVol":0.0374,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","floatShares":7000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.2613616885269208,"shares":7000000,"dividePrice":0,"high":36.21,"amplitude":0.003702,"preClose":35.93,"low":36.077,"week52Low":33.21,"pbRate":"--","week52High":36.73,"institutionHeld":0,"latestPrice":36.21,"eps":0,"divideRate":0,"volume":44514,"delay":0,"ttmEps":0,"open":36.15,"prevYearClose":35.79,"prevWeekClose":36.17,"prevMonthClose":36.17,"prevQuarterClose":35.79,"fiveDayClose":36.17,"twentyDayClose":35.98,"sixtyDayClose":35.8153},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MNA\",params:#limit:5,,,undefined,":[{"date":"2023-12-28","symbol":"MNA","amount":0.37752,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2024-01-05","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-05"},{"market":"US","date":"2020-12-30","symbol":"MNA","amount":0.76599,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2021-01-07","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MNA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.06134,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-07","value":0.76599,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-05","value":0.37752,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MNA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605520496","title":"Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2605520496","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605520496?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:30","pubTimestamp":1769085000,"startTime":"0","endTime":"0","summary":"Amendment reduces and simplifies royalty structure on Teverelix from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix as a first in class market product for ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3223643/0/en/Medicus-Pharma-Ltd-Announces-Amendment-to-LifeArc-License-Improving-Teverelix-Long-Term-Economic-and-Development-Profile.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1066051498.USD","LU2237443549.SGD","LU1718418525.SGD","LU1778281490.HKD","LU0314104364.USD","BCC","LU1935043023.USD","LU1496350171.SGD","LU1366333091.USD","LU1366192091.USD","LU0053666078.USD","LU1674673428.USD","LU1935042991.SGD","LU0170899867.USD","LU1066051225.USD","LU1935043536.SGD","LU2237443622.USD","LU0157215616.USD","LU0149725797.USD","91348","LU2236285917.USD","LU2417539215.USD","MDCX","LU2237443382.USD","LU1674673691.USD","LU1935042488.USD","LU2456880835.USD","APC","MNA","LU0786609619.USD","LU1066051811.HKD","LU0077335932.USD","LU2083900584.USD","BK4139","LU2420271590.USD","LU1935042215.USD","LU2237443978.SGD","BK4104","LU0882574139.USD","BK4567"],"gpt_icon":0},{"id":"2604118263","title":"Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118263","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118263?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:30","pubTimestamp":1768912200,"startTime":"0","endTime":"0","summary":"The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as SKNJCT-003 study approaches database lock, topline clinical data readout an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/20/3221602/0/en/Medicus-Pharma-Ltd-Celebrates-One-Year-on-Nasdaq-with-Opening-Bell-Ceremony-on-January-22-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","MDCX","LU2236285917.USD","LU2237443622.USD","LU2417539215.USD","LU1674673691.USD","MNA","LU2237443382.USD","LU1778281490.HKD","LU0149725797.USD","LU0170899867.USD","LU1935043536.SGD","LU2237443978.SGD","LU2420271590.USD","LU0077335932.USD","LU1718418525.SGD","LU2237443549.SGD","LU1496350171.SGD","LU1066051225.USD","LU1066051811.HKD","LU1935042488.USD","LU1935043023.USD","LU1935042991.SGD","LU0882574139.USD","LU1674673428.USD","LU0157215616.USD","LU1935042215.USD","APC","LU0786609619.USD","LU1066053197.SGD","LU2083900584.USD","LU0053666078.USD","LU1066051498.USD","LU2456880835.USD","BK4139","LU1366333091.USD","LU1366192091.USD"],"gpt_icon":0},{"id":"2602512792","title":"Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512792?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:30","pubTimestamp":1768221000,"startTime":"0","endTime":"0","summary":"The Company’s abstract, Evaluation of Teverelix in Healthy Female Volunteers, has been accepted for presentation at American Association of Clinical Endocrinology (AACE) Annual meeting 2026PHILADELPHI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216776/0/en/Medicus-Pharma-Ltd-Studies-Demonstrate-Long-Acting-Therapeutic-Approach-with-Stable-Bone-Turnover-in-Women.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0077335932.USD","LU1674673428.USD","LU2236285917.USD","LU1066051811.HKD","LU1066053197.SGD","LU2456880835.USD","LU2237443622.USD","MDCX","LU1496350171.SGD","LU1066051225.USD","BK4139","LU1366333091.USD","LU2417539215.USD","LU0314104364.USD","BCC","BK4104","LU0882574139.USD","MNA","LU1066051498.USD","LU1935043023.USD","LU2420271590.USD","UAE","LU1718418525.SGD","LU1935042215.USD","LU1935042991.SGD","LU2237443549.SGD","LU2083900584.USD","LU0149725797.USD","LU2237443978.SGD","LU0786609619.USD","LU2237443382.USD","LU0170899867.USD","APC","LU1935042488.USD","LU0053666078.USD","BK4567","LU1674673691.USD","LU1778281490.HKD","LU1935043536.SGD","LU1366192091.USD","LU0157215616.USD"],"gpt_icon":0},{"id":"2585462982","title":"Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462982","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462982?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Nov.  24, 2025  (GLOBE NEWSWIRE) -- November is Men’s Health Awareness Month, a time to spotlight the latest medical breakthroughs that may transform how we detect and treat cancer– espe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193414/0/en/Medicus-Pharma-Ltd-Explore-Novel-Treatment-Innovations-that-may-Revolutionize-Treatments-for-Prostate-and-Skin-Cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2417539215.USD","LU0786609619.USD","LU0170899867.USD","LU1496350171.SGD","LU1674673691.USD","LU1935043023.USD","LU1935043536.SGD","LU0157215616.USD","LU1366192091.USD","LU0314104364.USD","LU1718418525.SGD","BK4139","LU0882574139.USD","LU1674673428.USD","LU1366333091.USD","LU0077335932.USD","LU1778281490.HKD","BK4567","LU2083900584.USD","LU1935042215.USD","LU2237443382.USD","LU1935042488.USD","APC","LU1935042991.SGD","LU2237443622.USD","LU2237443978.SGD","LU2420271590.USD","LU2456880835.USD","MNA","LU0149725797.USD","BK4104","LU1066051225.USD","BCC","LU2236285917.USD","MDCX","LU1066053197.SGD","LU1066051811.HKD","LU2237443549.SGD","LU1066051498.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MNA\",params:#limit:6,delay:false,,,undefined,":[]}}